33 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
27522507	14	Synthetic, enzyme kinetic, and protein crystallographic studies of C-ß-d-glucopyranosyl pyrroles and imidazoles reveal and explain low nanomolar inhibition of human liver glycogen phosphorylase.	University of Thessaly
27624527	19	Synthesis of (benzimidazol-2-yl)aniline derivatives as glycogen phosphorylase inhibitors.	Egypt National Research Centre
26708111	41	Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition.	Universit£
25092521	50	Structure based inhibitor design targeting glycogen phosphorylase B. Virtual screening, synthesis, biochemical and biological assessment of novel N-acyl-ß-d-glucopyranosylamines.	University of Thessaly
23395662	2	Synthesis of tartaric acid analogues of FR258900 and their evaluation as glycogen phosphorylase inhibitors.	University of Debrecen
22229710	18	Binding evaluation of fragment-based scaffolds for probing allosteric enzymes.	Universit£
18595718	51	In vitro inhibition of glycogen-degrading enzymes and glycosidases by six-membered sugar mimics and their evaluation in cell cultures.	Hokuriku University
15214781	30	Identification, synthesis, and characterization of new glycogen phosphorylase inhibitors binding to the allosteric AMP site.	Novo Nordisk
11495595	24	Synthesis of and a comparative study on the inhibition of muscle and liver glycogen phosphorylases by epimeric pairs of d-gluco- and d-xylopyranosylidene-spiro-(thio)hydantoins and N-(d-glucopyranosyl) amides.	University of Debrecen
21788139	43	Ligand-based modelling followed by synthetic exploration unveil novel glycogen phosphorylase inhibitory leads.	Applied Science University
20493691	19	Discovery of a series of indan carboxylic acid glycogen phosphorylase inhibitors.	Astrazeneca
19095443	66	Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of Type 2 diabetes: 2. Optimization of serine and threonine ether amino acid residues.	Glaxosmithkline
19095442	70	Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes: 1. Identification of 1-amino-1-cycloalkyl carboxylic acid headgroups.	Glaxosmithkline
18723356	18	Synthesis and pharmacological evaluation of bis-3-(3,4-dichlorophenyl)acrylamide derivatives as glycogen phosphorylase inhibitors.	Astellas Pharma
18554908	63	Amino acid anthranilamide derivatives as a new class of glycogen phosphorylase inhibitors.	Glaxosmithkline
17451960	5	Synthesis and glycogen phosphorylase inhibitor activity of 2,3-dihydrobenzo[1,4]dioxin derivatives.	University of Debrecen
16970395	14	Iminosugars as potential inhibitors of glycogenolysis: structural insights into the molecular basis of glycogen phosphorylase inhibition.	The National Hellenic Research Foundation
16945526	19	Novel thienopyrrole glycogen phosphorylase inhibitors: synthesis, in vitro SAR and crystallographic studies.	Astrazeneca
16942879	24	Synthesis and structure-activity relationships of 3-phenyl-2-propenamides as inhibitors of glycogen phosphorylase a.	Glaxosmithkline
16190745	85	Acyl ureas as human liver glycogen phosphorylase inhibitors for the treatment of type 2 diabetes.	Sanofi-Aventis Deutschland
15603973	88	5-Chloroindoloyl glycine amide inhibitors of glycogen phosphorylase: synthesis, in vitro, in vivo, and X-ray crystallographic characterization.	Pfizer
14643331	71	Novel 3,4-dihydroquinolin-2(1H)-one inhibitors of human glycogen phosphorylase a.	Merck Research Laboratories
14592521	50	A new class of glycogen phosphorylase inhibitors.	Merck Research Laboratories
14505637	40	Glucose-lowering in a db/db mouse model by dihydropyridine diacid glycogen phosphorylase inhibitors.	Merck Research Laboratories
31767404	9	The architecture of hydrogen and sulfur ?-hole interactions explain differences in the inhibitory potency of C-?-d-glucopyranosyl thiazoles, imidazoles and an N-?-d glucopyranosyl tetrazole for human liver glycogen phosphorylase and offer new insights to structure-based design.	University of Thessaly
9685232	26	Indole-2-carboxamide inhibitors of human liver glycogen phosphorylase.	Pfizer
29453094	19	A multidisciplinary study of 3-(?-d-glucopyranosyl)-5-substituted-1,2,4-triazole derivatives as glycogen phosphorylase inhibitors: Computation, synthesis, crystallography and kinetics reveal new potent inhibitors.	University of Debrecen
28925695	25	Nanomolar Inhibitors of Glycogen Phosphorylase Based on?-d-Glucosaminyl Heterocycles: A Combined Synthetic, Enzyme Kinetic, and Protein Crystallography Study.	University of Debrecen
11961053	26	Biochemical and behavioral characterization of novel methylphenidate analogs.	Mercer University
11752130	5	The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin.	Merck Research Laboratories
19101474	3	Targeting a uniquely nonspecific prenyl synthase with bisphosphonates to combat cryptosporidiosis.	University of Toronto